Reversible regulation of aptamer activity with effector-responsive hairpin oligonucleotides

Na Li

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Aptamers are oligonucleotides that can bind to various nonnucleic acid molecular targets in a high affinity and specificity. As an emerging class of therapeutic agents, aptamers offer an unparalleled advantage over other classes of therapeutic agents: the possibility to rationally regulate the therapeutic activity of aptamers. Most existing strategies for regulating the aptamer activity have a limited specificity and/or reversibility. Herein we report a simple, generic strategy to simultaneously achieve specificity and reversibility by exploiting the spontaneous conformational change of hairpin oligonucleotides upon the specific recognition of nucleic acid effectors. The effector-responsive hairpin oligonucleotide consists of a sensing loop that recognizes a particular nucleic acid effector, an aptamer stem that inhibits a certain therapeutic target, and an antidote stem that is complementary to the aptamer. Upon the introduction/removal of the effector, the hairpin oligonucleotide undergoes a conformational change that activates/deactivates the aptamer's inhibiting activity on the therapeutic target. This new strategy has been demonstrated with an anticoagulant aptamer that binds and inhibits human α-thrombin.

Original languageEnglish
Pages (from-to)77-84
Number of pages8
JournalJournal of laboratory automation
Volume18
Issue number1
DOIs
StatePublished - Jun 3 2013

Fingerprint

Oligonucleotides
Nucleic acids
Nucleic Acids
Therapeutics
Antidotes
Thrombin
Anticoagulants
Acids

Keywords

  • Antidotes
  • Aptamers
  • Hairpin oligonucleotides
  • Nucleic acid effectors
  • Reversible anticoagulant

ASJC Scopus subject areas

  • Computer Science Applications
  • Medical Laboratory Technology

Cite this

Reversible regulation of aptamer activity with effector-responsive hairpin oligonucleotides. / Li, Na.

In: Journal of laboratory automation, Vol. 18, No. 1, 03.06.2013, p. 77-84.

Research output: Contribution to journalArticle

@article{782eaf8588d949f28152ba27461e5d97,
title = "Reversible regulation of aptamer activity with effector-responsive hairpin oligonucleotides",
abstract = "Aptamers are oligonucleotides that can bind to various nonnucleic acid molecular targets in a high affinity and specificity. As an emerging class of therapeutic agents, aptamers offer an unparalleled advantage over other classes of therapeutic agents: the possibility to rationally regulate the therapeutic activity of aptamers. Most existing strategies for regulating the aptamer activity have a limited specificity and/or reversibility. Herein we report a simple, generic strategy to simultaneously achieve specificity and reversibility by exploiting the spontaneous conformational change of hairpin oligonucleotides upon the specific recognition of nucleic acid effectors. The effector-responsive hairpin oligonucleotide consists of a sensing loop that recognizes a particular nucleic acid effector, an aptamer stem that inhibits a certain therapeutic target, and an antidote stem that is complementary to the aptamer. Upon the introduction/removal of the effector, the hairpin oligonucleotide undergoes a conformational change that activates/deactivates the aptamer's inhibiting activity on the therapeutic target. This new strategy has been demonstrated with an anticoagulant aptamer that binds and inhibits human α-thrombin.",
keywords = "Antidotes, Aptamers, Hairpin oligonucleotides, Nucleic acid effectors, Reversible anticoagulant",
author = "Na Li",
year = "2013",
month = "6",
day = "3",
doi = "10.1177/2211068212448429",
language = "English",
volume = "18",
pages = "77--84",
journal = "JALA - Journal of the Association for Laboratory Automation",
issn = "2211-0682",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Reversible regulation of aptamer activity with effector-responsive hairpin oligonucleotides

AU - Li, Na

PY - 2013/6/3

Y1 - 2013/6/3

N2 - Aptamers are oligonucleotides that can bind to various nonnucleic acid molecular targets in a high affinity and specificity. As an emerging class of therapeutic agents, aptamers offer an unparalleled advantage over other classes of therapeutic agents: the possibility to rationally regulate the therapeutic activity of aptamers. Most existing strategies for regulating the aptamer activity have a limited specificity and/or reversibility. Herein we report a simple, generic strategy to simultaneously achieve specificity and reversibility by exploiting the spontaneous conformational change of hairpin oligonucleotides upon the specific recognition of nucleic acid effectors. The effector-responsive hairpin oligonucleotide consists of a sensing loop that recognizes a particular nucleic acid effector, an aptamer stem that inhibits a certain therapeutic target, and an antidote stem that is complementary to the aptamer. Upon the introduction/removal of the effector, the hairpin oligonucleotide undergoes a conformational change that activates/deactivates the aptamer's inhibiting activity on the therapeutic target. This new strategy has been demonstrated with an anticoagulant aptamer that binds and inhibits human α-thrombin.

AB - Aptamers are oligonucleotides that can bind to various nonnucleic acid molecular targets in a high affinity and specificity. As an emerging class of therapeutic agents, aptamers offer an unparalleled advantage over other classes of therapeutic agents: the possibility to rationally regulate the therapeutic activity of aptamers. Most existing strategies for regulating the aptamer activity have a limited specificity and/or reversibility. Herein we report a simple, generic strategy to simultaneously achieve specificity and reversibility by exploiting the spontaneous conformational change of hairpin oligonucleotides upon the specific recognition of nucleic acid effectors. The effector-responsive hairpin oligonucleotide consists of a sensing loop that recognizes a particular nucleic acid effector, an aptamer stem that inhibits a certain therapeutic target, and an antidote stem that is complementary to the aptamer. Upon the introduction/removal of the effector, the hairpin oligonucleotide undergoes a conformational change that activates/deactivates the aptamer's inhibiting activity on the therapeutic target. This new strategy has been demonstrated with an anticoagulant aptamer that binds and inhibits human α-thrombin.

KW - Antidotes

KW - Aptamers

KW - Hairpin oligonucleotides

KW - Nucleic acid effectors

KW - Reversible anticoagulant

UR - http://www.scopus.com/inward/record.url?scp=84878299398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878299398&partnerID=8YFLogxK

U2 - 10.1177/2211068212448429

DO - 10.1177/2211068212448429

M3 - Article

C2 - 22651934

AN - SCOPUS:84878299398

VL - 18

SP - 77

EP - 84

JO - JALA - Journal of the Association for Laboratory Automation

JF - JALA - Journal of the Association for Laboratory Automation

SN - 2211-0682

IS - 1

ER -